169 related articles for article (PubMed ID: 26507575)
1. Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells.
Lambert AW; Wong CK; Ozturk S; Papageorgis P; Raghunathan R; Alekseyev Y; Gower AC; Reinhard BM; Abdolmaleky HM; Thiagalingam S
Mol Cancer Res; 2016 Jan; 14(1):103-13. PubMed ID: 26507575
[TBL] [Abstract][Full Text] [Related]
2. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
[TBL] [Abstract][Full Text] [Related]
3. The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation.
Kikuchi Y; Kunita A; Iwata C; Komura D; Nishiyama T; Shimazu K; Takeshita K; Shibahara J; Kii I; Morishita Y; Yashiro M; Hirakawa K; Miyazono K; Kudo A; Fukayama M; Kashima TG
Am J Pathol; 2014 Mar; 184(3):859-70. PubMed ID: 24418260
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
[TBL] [Abstract][Full Text] [Related]
5. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
6. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.
Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G
J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093
[TBL] [Abstract][Full Text] [Related]
7. Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
Field S; Uyttenhove C; Stroobant V; Cheou P; Donckers D; Coutelier JP; Simpson PT; Cummings MC; Saunus JM; Reid LE; Kutasovic JR; McNicol AM; Kim BR; Kim JH; Lakhani SR; Neville AM; Van Snick J; Jat PS
Int J Cancer; 2016 Apr; 138(8):1959-70. PubMed ID: 26619948
[TBL] [Abstract][Full Text] [Related]
8. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
10. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
Tominaga K; Minato H; Murayama T; Sasahara A; Nishimura T; Kiyokawa E; Kanauchi H; Shimizu S; Sato A; Nishioka K; Tsuji EI; Yano M; Ogawa T; Ishii H; Mori M; Akashi K; Okamoto K; Tanabe M; Tada KI; Tojo A; Gotoh N
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):625-630. PubMed ID: 30587593
[TBL] [Abstract][Full Text] [Related]
12. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
14. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
15. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression.
Shao R; Bao S; Bai X; Blanchette C; Anderson RM; Dang T; Gishizky ML; Marks JR; Wang XF
Mol Cell Biol; 2004 May; 24(9):3992-4003. PubMed ID: 15082792
[TBL] [Abstract][Full Text] [Related]
16. Cytokines driving breast cancer stemness.
Chin AR; Wang SE
Mol Cell Endocrinol; 2014 Jan; 382(1):598-602. PubMed ID: 23562748
[TBL] [Abstract][Full Text] [Related]
17. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
18. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
[TBL] [Abstract][Full Text] [Related]
19. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells.
Watanabe T; Yasue A; Fujihara S; Tanaka E
Arch Oral Biol; 2012 Jan; 57(1):52-9. PubMed ID: 21885032
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
